Resource type
All
Topics

Whitepaper

90% of GLP-1 demand never becomes therapy

Demand for glucagon-like peptide-1 therapies has never been clearer. Yet for obesity-indicated GLP-1s, 90 percent of that demand never becomes treatment. Payer rejections, cost concerns and early drop-off…

Whitepaper

Pharmacy Outlook: Fall 2026 Edition

Powered by Accelerate Pharmacy Solutions, the Pharmacy Outlook: Fall 2026 Edition features insights from 111 health system pharmacy leaders on the forces reshaping pharmacy strategy and performance. The…

Advertisement